Efficacy and Safety of Fluticasone Propionate(FP)/ Salmeterol Xinafoate (SLM) Hydro Fluoro Alkane (HFA) Metered Dose Inhaler (MDI) in Pediatric Patients With Bronchial Asthma

NCT02113436 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

300

Enrollment

INDUSTRY

Sponsor class

Conditions

Asthma

Interventions

DRUG: FP/ SLM HFA MDI 50/25 mcg
DRUG: FP HFA MDI 50 mcg

Sponsor

GlaxoSmithKline